Streetbeat News

Stock Prices

RDY

Dr Reddy's Laboratories has issued a statement in response to a Sky News article dated January 16, 2024, which suggested that the Indian pharmaceutical company was considering an acquisition of Nicotinell. Dr Reddy's stated that it does not comment on market speculations, providing no confirmation or details regarding the potential deal.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 5:14 pm

GME

GameStop Corp (NYSE:GME) is closing its NFT marketplace due to ongoing regulatory uncertainty in the crypto space. The platform, which supported gaming NFTs and collectibles on Ethereum scaling networks Immutable X and Loopring, will cease operations on February 2, 2024. GameStop had previously terminated its NFT wallet four months earlier for similar reasons. The company had ventured into the cryptocurrency space in January 2022 but announced a reduced focus on the industry in December 2022. The former CFO resigned in August 2022 during a reevaluation of GameStop's crypto initiatives.

Portfolio Pulse from Franca Quarneti

January 16, 2024 | 5:12 pm

DOGEUSD

Dogecoin (DOGE) is experiencing significant whale activity and a surge in daily active addresses, suggesting a potential big move. A transfer of 990 million DOGE ($79.8 million) occurred between unknown wallets. Daily active addresses peaked at 250,289 on Dec. 19, a substantial increase. Dogecoin's liquidity ranking is fourth among the top 50 crypto assets. Elon Musk's AI chatbot Grok on platform X endorsed Dogecoin for Twitter use, citing Musk's support and the active Dogecoin community. Despite recent stability, Dogecoin may be poised for a price move, with a potential rally to $0.10 predicted by a crypto analyst.

Portfolio Pulse from Khyathi Dalal

January 16, 2024 | 5:11 pm

BRBR

Barclays analyst Lauren Lieberman has maintained an Overweight rating on BellRing Brands (NYSE:BRBR) and increased the price target from $54 to $56.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 5:07 pm

AAPL

GOOG

GOOGL

The U.S. Supreme Court has rejected Apple Inc's appeal in an antitrust lawsuit, allowing a lower court ruling to stand which found Apple's App Store restrictions violated California's Unfair Competition Law. This decision enables developers to direct users to alternative payment systems, bypassing Apple's up to 30% commission fees. Epic Games, involved in the case, had previously filed a similar lawsuit against Alphabet Inc over Google's Play Store fees.

Portfolio Pulse from Anusuya Lahiri

January 16, 2024 | 5:07 pm

WAB

B of A Securities analyst Ken Hoexter upgraded Westinghouse Air Brake (NYSE:WAB) from Neutral to Buy and increased the price target from $128 to $150.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 5:02 pm

PTVE

Pactiv Evergreen (NASDAQ:PTVE) has received 4 analyst ratings in the last three months, with a positive shift in sentiment and an increased average 12-month price target of $16.00, up 37.1% from the previous $11.67. Analysts from UBS, Citigroup, B of A Securities, and RBC Capital have raised their price targets, reflecting optimism about the company's performance. Despite challenges in revenue growth and net margin, Pactiv Evergreen's ROE and ROA outperform industry benchmarks, and its conservative debt management is noted.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:01 pm

EQIX

Truist Securities analyst Anthony Hau has upgraded Equinix (NASDAQ:EQIX) from Hold to Buy and increased the price target from $871 to $915.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 5:01 pm

UNH

UnitedHealth Group (NYSE:UNH) has received mixed reviews from 10 analysts over the past quarter, with 1 bullish, 7 somewhat bullish, 1 indifferent, and 1 somewhat bearish rating. The average 12-month price target is $573.0, down from $579.25, with a high estimate of $610.00 and a low of $480.00. Analysts have adjusted their ratings and price targets, reflecting their views on the company's market position and financial performance. UnitedHealth Group is a major health insurer with significant market capitalization and revenue growth, but its debt-to-equity ratio is higher than the industry average.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:00 pm

SBUX

Morgan Stanley upgraded Starbucks (NASDAQ:SBUX) to Overweight with a new price target of $120.00, up from $112.00. Starbucks shares are currently trading at $92.23, and the new target suggests a potential 30.11% increase. Starbucks operates over 38,000 stores globally and generates revenue through various segments including company-operated stores and product sales.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 5:00 pm